Harris Erik Insider Trades

Insider Trading History

Track insider trading activity for Harris Erik. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $2.76M 118,410 shares
Last Trade
Apr 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.93M 78,855 shares
$24.52
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $2.09M 89,515 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$240k 10,539 shares
$22.80
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $2.32M 99,498 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$272k 11,643 shares
$23.39
$23.31
Rezolute
Rezolute RZLT
Director
Holding Value $94.7k 21,000 shares
Last Trade
Nov 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$335k 33,000 shares
$10.16
$4.51
Rezolute
Rezolute RZLT
Director
Holding Value $271k 60,000 shares
Last Trade
Mar 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$173k 60,000 shares
$2.89
$4.51
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $2.05M 87,855 shares
Last Trade
Mar 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$636k 15,103 shares
$42.10
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $2.39M 102,419 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.3M 30,246 shares
$42.92
$23.31
Inozyme Pharma
Inozyme Pharma INZY
Director
Holding Value $224k 56,000 shares
Last Trade
Oct 03, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$283k 56,000 shares
$5.06
$4.00
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $361k 17,901 shares
Last Trade
May 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$332k 17,901 shares
$18.56
$20.14
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $1.57M 67,163 shares
Last Trade
Mar 01, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$256k 4,768 shares
$53.76
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $1.67M 71,638 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.84M 34,200 shares
$53.69
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $1.2M 51,281 shares
Last Trade
Sep 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$228k 6,000 shares
$37.96
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $1.34M 57,281 shares
Last Trade
Jun 19, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.7k 305 shares
$48.20
$23.31
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $255k 12,649 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$391k 12,649 shares
$30.92
$20.14
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $1.42M 60,823 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.8M 39,400 shares
$45.65
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $1.34M 57,344 shares
Last Trade
Mar 01, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$166k 3,664 shares
$45.25
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $843k 36,160 shares
Last Trade
Jun 19, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.2k 295 shares
$54.78
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $520k 22,317 shares
Last Trade
Mar 01, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$181k 2,713 shares
$66.62
$23.31
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
EVP & Chief Commercial Officer
Holding Value $847k 36,317 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.68M 24,900 shares
$67.37
$23.31
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $415k 20,607 shares
Last Trade
Feb 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$927k 27,476 shares
$33.74
$20.14

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up